One of Australia's largest real-world studies of younger adults with advanced bowel cancer has identified important ...

Enfortumab vedotin plus pembrolizumab significantly improves EFS and OS in cisplatin-ineligible MIBC patients, offering a new treatment option. The EV-303 trial is the first to show systemic treatment ...

What Is This Treatment and Why Does It Matter? The FDA approved two options of medicine for adults with a certain type of bladder cancer. This cancer is called muscle-invasive bladder cancer. It means ...

Cancer treatments have evolved, improving survival rates and quality of life, challenging the notion of cancer as a death sentence. Media and fundraising often portray cancer fatalistically, ...

A cancer survivor reflects on body image, grief and emotional healing 12 years after treatment, and why healing doesn’t have ...